Stephen Murphy, Co-Founder and Managing Director of Prohibition Partners spoke with me about Germany’s legalization of adult cannabis use marking a significant development in Europe, and how it will impact other countries. They discussed innovative mental health solutions leveraging AI to customize content for individuals and measure therapy effectiveness. Challenges in the US cannabis market were highlighted, attributing complexity to state regulations, federal laws, and business obstacles. Insights covered industry trends like changes in import markets, evolving consumer perceptions, and challenges faced by investors and companies. Key themes emphasized evidence-based mental health treatments, strategic business growth amidst global regulatory changes, and fostering collaboration across sectors. The Cannabis Europa Conference was recommended as a valuable networking opportunity in the industry landscape.
The Happiness Myth: Why Your Brain is Designed for Ups and Downs
Loretta Graziano Breuning, founder of the Inner Mammal Institute, challenges the cultural myth of constant happiness. Drawing on her work examining how “happy chemicals”—dopamine, serotonin, oxytocin, and endorphins—evolved in animals, Breuning explains that our brains Read more